FDA expands use of Kisqali
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
FDA Expands Use of Breast Cancer Drug Kisqali
The FDA approval of Kisqali for this early breast cancer population, including those with NO [hasn't spread to nearby lymph nodes] disease, is a pivotal moment in improving our approach to care,” said Dr.
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.
FDA expands approval for drug to treat early-stage breast cancer
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. NBC News' Kathy Park speaks to a woman who took the drug while it was in clinical trials and is now cancer free.
FDA awards Novartis expanded approval for breast cancer therapy
The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients will be able to receive it.
Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm
Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the company recently received an extended approval for it from the U.S. Food and Drug Administration.
Breast cancer drug Kisqali gets FDA approval to prevent cancer recurrence
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce the chances of a patient's breast cancer coming back by 25%.
FDA expanded their approval on drug cancer drug
First News
Reuters7d
Approvals News | Today's Latest Stories | Reuters
Stories on US FDA approving injectable Roche multiple sclerosis therapy are withdrawn The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients ...
BioSpace4d
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...
Lifehacker3d
These Apple Devices Are Now FDA-Approved
Over the past week, the FDA cleared two of Apple's new health features: The agency approved AirPods Pro 2's new hearing-aid feature, as well as sleep apnea detection on compatible Apple Watches.
Agri-Pulse8d
Food system stakeholders push FDA for delayed, staggered traceability timeline
Food safety stakeholders continue to warn the Food and Drug Administration that much of the supply chain is not ready to ...
AppleInsider8d
FDA approves AirPods Pro 2 hearing aid features
At the time, the FDA was in the process of approving the software, but by Thursday, it had given it the green light. The FDA's confirmation says the update is its first authorization of an "over ...
CBS News3d
FDA approves Apple Watch sleep apnea detection tool
According to the FDA's approval notice, the Apple Watch sleep apnea function is not a diagnostic tool, but rather an over-the-counter device designed to assess watch-wearers' risk of sleep apnea.
Popular Science2d
FDA approves Apple Watch screening for sleep apnea risk
Apple has received Federal Drug Association (FDA) approval for a new Watch feature it says can detect signs of sleep apnea. The tool, available in several Watch models starting this week ...
Tom's Guide4d
Apple Watch's sleep apnea notifications get FDA approval — here's why I can't wait to try it
According to the FDA, the sleep apnea detection feature on ... similarly to a device designed for sleep apnea detection. The approval was officially granted on 9/13/2024, but it took a little ...
dermatologyadvisor9d
FDA Expands Approval of ACAM2000 to Include Prevention of Mpox Disease
The FDA has approved ACAM2000 for prevention of mpox disease in individuals determined to be at high risk for mpox infection.
Medindia7h
Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia™, a safe, highly effective, and convenient once-daily oral JAK ...